Date prepared: June 6, 2023
Abbreviated name of the issuer: CELON PHARMA S.A.
Subject: Notification on the acquisition of C-series shares of Celon Pharma S.A. by a person discharging managerial responsibilities
Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) – information on transactions conducted by persons discharging managerial responsibilities.
Content of the report:
The Management Board of Celon Pharma S.A. (the “Company”) hereby informs that on June 5, 2022, it received a notification from a person discharging managerial responsibilities in the Company – Ms Dorota Zwolińska – on her acquisition, under the Incentive Program for Members of the Management Board, of C-series shares of the Company issued under a conditional share capital increase in exchange for A-series warrants.
The Company attaches the notification in question.